Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​Needle Electromyography (EMG) and Nerve Conduction Studies (NCS) coverage criteria changes

January 6, 2022

Effective March 21, 2022, Independence will update coverage criteria for diagnosing or confirming radiculopathy using needle electromyography (EMG) and nerve conduction studies (NCS).

The changes align with the current recommendations from the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM).

The policy changes include:

Needle Electromyography (EMG) Studies

  • Needle electromyography (EMG) when not conducted and interpreted at the same time as a nerve conduction study (NCS) for the sole purpose of diagnosing or confirming radiculopathy is considered not medically necessary.

Nerve Conduction Studies (NCS)

  • ​Nerve conduction studies (NCS) when not conducted and interpreted at the same time as needle electromyography (EMG) for the sole purpose of diagnosing or confirming radiculopathy are considered not medically necessary.

Commercial and Medicare Advantage Policy Notifications were posted December 20, 2021, for:


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.